Primary Recipient

TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, INC.

Amount

$313,200.00

Award Date

9/28/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

This study develops novel approaches based on the p14ARF tumor suppressor and Spermidine-CoA-based inhibitors of histone acetylation to improve cellular responses to topoisomerase I-targeted chemotherapies and reverse therapy resistance, a major obstacle

Vendors Connected to Award

Vendor	Role	Amount
Air Gas West	Primary vendor	$87.82
Fisher Scientific	Primary vendor	$1,249.56
VWR International	Primary vendor	$435.90
Harlan Laboratory	Primary vendor	$7,264.27
BATJ	Primary vendor	$276.00
Fermentas Inc.	Primary vendor	$2,079.99
Intergrated DNA Technologies	Primary vendor	$1,164.93
MP Biomedical	Primary vendor	$661.14
New England Bio Labs	Primary vendor	$470.82
Genesee Scientifitc	Primary vendor	$202.30
Invitrogen Coproration	Primary vendor	$1,977.48
Genewiz Inc.	Primary vendor	$370.00
Lonza Rockland	Primary vendor	$1,041.43
Santa Cruz Biological	Primary vendor	$2,238.37
Sigma - Aldrich	Primary vendor	$2,000.49
BioExpress Corp	Primary vendor	$100.76
BioRad Laboratories	Primary vendor	$127.12
InvivoGen	Primary vendor	$194.00
FedEx	Primary vendor	$94.20
Promega	Primary vendor	$2,181.89
Qiagen Inc.	Primary vendor	$230.76
Retrogen	Primary vendor	$150.00
TopoGen, Inc.	Primary vendor	$363.30
Abcam Inc.	Primary vendor	$374.00
Bethyl Laboratories	Primary vendor	$333.65
Millipore Corporation	Primary vendor	$205.35